CMV Antiviral Therapy

Valganciclovir

Powerful oral antiviral to prevent and treat cytomegalovirus infections.

Valganciclovir is a potent oral antiviral medication used for the treatment and prevention of cytomegalovirus (CMV) infections in immunocompromised patients, such as organ transplant recipients or those with advanced HIV. As a prodrug of ganciclovir, it provides high bioavailability, effectively inhibiting CMV replication to prevent vision loss, systemic infection, and organ rejection in transplant patients.

Ingredients dosages:

Frequency:

Quantity:

Not sure about dosages? Don't worry, your provider will adjust or confirm your selection after checkout.

Total

$0.00

Here's what happens next:

  1. 1

    Product checkout

    We'll direct you to our product detail page where you can start the checkout process. You'll be charged for the medical consultation but the medication charge is a hold until the official provider review.

  2. 2

    Comprehensive Medical Questionnaire

    After purchase, you'll be directed to a medical assessment covering your medical history, current medications, and specific symptoms.

  3. 3

    Licensed Provider Review

    A licensed healthcare provider reviews your complete medical profile, ensuring this treatment is safe and appropriate for you.

  4. 4

    Personalized Treatment Plan

    Your provider may recommend an adjustment to your prescription based on your full medical profile before approving your treatment.

HIPAA Compliant
Certified Providers

  • Effectively prevents CMV disease in high-risk solid organ transplant recipients when used prophylactically

  • Reduces the risk of CMV retinitis progression in HIV patients, preserving vision

  • Provides greater oral bioavailability compared to ganciclovir capsules, ensuring improved systemic absorption

  • Decreases viral load quickly, minimizing risk of life-threatening systemic CMV complications

  • Improves transplant outcomes by lowering incidence of CMV-related organ rejection and infection

  • Valganciclovir: A prodrug of ganciclovir that, after oral absorption, is converted to ganciclovir, inhibiting viral DNA synthesis and CMV replication within infected cells

  • Take with food to enhance absorption

  • Dosage and duration depend on treatment versus prophylaxis indication and renal function

  • For prevention in transplant patients, typically 900mg once daily starting within 10 days post-transplant for 100-200 days as prescribed

  • For CMV retinitis treatment, dosing may begin with higher induction doses, then maintenance therapy

  • Always follow your provider’s instructions carefully and ensure adequate hydration